American Heart Association Disappointed by CMS’ Inaction on Medication Therapy Management Program
Washington, D.C., May 20, 2014 — American Heart Association President Mariell Jessup, M.D., issued the following comments today on the Obama Administration’s 2015 Medicare Advantage and Medicare Part D Final Rule:
“It is disheartening that the proposed changes to the Medication Therapy Management (MTM) Program were not included in this final rule. These vital improvements would have expanded MTM services to more than half of all Medicare Part D beneficiaries – many of whom have some form of cardiovascular disease.
The association has long advocated for changes to the program that would increase the number of eligible individuals and boost the use of MTM services. We strongly believe that MTM can not only improve medication adherence, but reduce the risk of adverse events and help control health care costs, particularly among patients with cardiovascular conditions. That’s why this is truly a missed opportunity to provide more patients who are struggling with the support they need.
We believe that the current MTM eligibility criteria should be clarified and streamlined so that it does not restrict patient access to these valuable services. Although the proposed changes would have expanded MTM services, they would not have infringed on the flexibility of health plans to create programs that best meet the needs of their participants.
We strongly urge the Centers for Medicare and Medicaid Services to include the proposed changes in future rulemaking. We also call on Congress to pass the Medication Therapy Management Act of 2013 so that a greater number of Medicare beneficiaries can receive access to much-needed MTM services.”
For media inquiries, please contact Abbey Race at 202-785-7905 or email@example.com.